Search Results - "Bijen, Helena M."
-
1
Mutated nucleophosmin 1 as immunotherapy target in acute myeloid leukemia
Published in The Journal of clinical investigation (01-02-2019)“…The most frequent subtype of acute myeloid leukemia (AML) is defined by mutations in the nucleophosmin 1 (NPM1) gene. Mutated NPM1 (ΔNPM1) is an attractive…”
Get full text
Journal Article -
2
Preclinical Strategies to Identify Off-Target Toxicity of High-Affinity TCRs
Published in Molecular therapy (02-05-2018)“…Adoptive transfer of T cells engineered with a cancer-specific T cell receptor (TCR) has demonstrated clinical benefit. However, the risk for off-target…”
Get full text
Journal Article -
3
Specific T Cell Responses against Minor Histocompatibility Antigens Cannot Generally Be Explained by Absence of Their Allelic Counterparts on the Cell Surface
Published in Proteomics (Weinheim) (01-06-2018)“…Allogeneic stem cell transplantation has emerged as immunotherapy in the treatment of a variety of hematological malignancies. Its efficacy depends on…”
Get full text
Journal Article -
4
Mutated NPM1 As Target for Immunotherapy of Acute Myeloid Leukemia
Published in Blood (08-12-2017)“…In AML, nucleophosmin (NPM1) is the gene that is most frequently mutated. Mutated NPM1 (ΔNPM1) is a driver gene that is essential for malignant transformation…”
Get full text
Journal Article